BioSpace News Archive

Insignia Health, a leading provider of health activation solutions and services, recently announced availability of the Patient Activation Measure® (PAM®) SMART App through Epic’s App Orchard.

DuPont announced it has named 12 outstanding scientists as recipients of the Lavoisier Medal of Technical Achievement and the Pedersen Award Medal.

Digirad Corporation (NASDAQ:DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will be presenting at the LD 500 Virtual Conference, on Tuesday, September 1

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the appointment of Tammy Sarnelli as Global Head of Regulatory Affairs.

Plakous Therapeutics, Inc. announced that it has signed a know-how license agreement with Mayo Clinic. The multi-year agreement will focus on understanding the results of a natural history study of the factors associated with necrotizing enterocolitis (NEC), a rare disease affecting premature babies. Plakous has received Orphan

Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, today affirmed the full availability of Triptodur ® (triptorelin), a twice yearly injectable gonadotropin releasing hormone agonist (GnRHa) for the treatment of pediatric

SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced today that Medica published an exclusive, positive iFuse coverage policy effective August 19, 2020.